| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| BWAYBrainsWay Ltd. | 452.42M | 23.10 | 128.33 | 29.04% | 12.73% | 8.92% | 1.44% | 0.09 |
| INSPInspire Medical Systems, Inc. | 2.8B | 96.47 | 55.13 | 28.49% | 5.05% | 6.69% | 3.25% | 0.05 |
| TIVCTivic Health Systems, Inc. | 3.11M | 1.23 | -0.06 | -33.67% | -15.57% | -134.25% | ||
| COCHEnvoy Medical, Inc. | 19.42M | 0.67 | -0.45 | -28.8% | -104.75% | |||
| HSDTSolana Company | 128.03M | 3.10 | -0.72 | -19.25% | -393.59% | -6.89% | 0.01 | |
| NXLNexalin Technology, Inc. | 12.87M | 0.69 | -0.83 | 52.35% | -55.3% | -182.01% | ||
| CVRXCVRx, Inc. | 143.37M | 5.47 | -2.06 | 30.53% | -92.95% | -108.26% | 0.71 | |
| VANIVivani Medical, Inc. | 91.92M | 1.26 | -2.93 | -19.88% | 1.10 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 6.26M | 6.05M | 13.04M | 22.47M | 39.3M | 51.29M |
| Revenue Growth % | - | -0.03% | 1.15% | 0.72% | 0.75% | 0.31% |
| Cost of Goods Sold | 1.68M | 1.44M | 3.64M | 5M | 6.26M | 8.33M |
| COGS % of Revenue | 0.27% | 0.24% | 0.28% | 0.22% | 0.16% | 0.16% |
| Gross Profit | 4.57M | 4.61M | 9.4M | 17.47M | 33.04M | 42.96M |
| Gross Margin % | 0.73% | 0.76% | 0.72% | 0.78% | 0.84% | 0.84% |
| Gross Profit Growth % | - | 0.01% | 1.04% | 0.86% | 0.89% | 0.3% |
| Operating Expenses | 14.77M | 16.13M | 35.36M | 60M | 76.14M | 102.45M |
| OpEx % of Revenue | 2.36% | 2.66% | 2.71% | 2.67% | 1.94% | 2% |
| Selling, General & Admin | 6.11M | 9.72M | 27.86M | 50.05M | 64.51M | 91.32M |
| SG&A % of Revenue | 0.98% | 1.61% | 2.14% | 2.23% | 1.64% | 1.78% |
| Research & Development | 8.66M | 6.41M | 7.5M | 9.95M | 11.63M | 11.13M |
| R&D % of Revenue | 1.38% | 1.06% | 0.58% | 0.44% | 0.3% | 0.22% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.19M | -11.51M | -25.97M | -42.53M | -43.1M | -59.49M |
| Operating Margin % | -1.63% | -1.9% | -1.99% | -1.89% | -1.1% | -1.16% |
| Operating Income Growth % | - | -0.13% | -1.26% | -0.64% | -0.01% | -0.38% |
| EBITDA | -10.14M | -11.44M | -25.8M | -42.12M | -42.58M | -58.87M |
| EBITDA Margin % | -1.62% | -1.89% | -1.98% | -1.87% | -1.08% | -1.15% |
| EBITDA Growth % | - | -0.13% | -1.26% | -0.63% | -0.01% | -0.38% |
| D&A (Non-Cash Add-back) | 56K | 75K | 168K | 412K | 522K | 619K |
| EBIT | -12.84M | -11.55M | -40.77M | -41.15M | -39.25M | -55.51M |
| Net Interest Income | -1.72M | -2.47M | -2.22M | -165K | -1.8M | -4.4M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.72M | 2.47M | 2.22M | 165K | 1.8M | 4.4M |
| Other Income/Expense | -4.37M | -2.51M | -17.02M | 1.21M | 2.05M | -420K |
| Pretax Income | -14.56M | -14.02M | -42.99M | -41.32M | -41.05M | -59.91M |
| Pretax Margin % | -2.33% | -2.32% | -3.3% | -1.84% | -1.04% | -1.17% |
| Income Tax | 73K | 85K | 91K | 109K | 147K | 55K |
| Effective Tax Rate % | 1.01% | 1.01% | 1% | 1% | 1% | 1% |
| Net Income | -14.63M | -14.11M | -43.08M | -41.43M | -41.2M | -59.97M |
| Net Margin % | -2.34% | -2.33% | -3.3% | -1.84% | -1.05% | -1.17% |
| Net Income Growth % | - | 0.04% | -2.05% | 0.04% | 0.01% | -0.46% |
| Net Income (Continuing) | -14.63M | -14.11M | -43.08M | -41.43M | -41.2M | -59.97M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.76 | -0.73 | -2.11 | -2.02 | -1.99 | -2.65 |
| EPS Growth % | - | 0.04% | -1.89% | 0.04% | 0.01% | -0.33% |
| EPS (Basic) | -0.76 | -0.73 | -2.11 | -2.02 | -1.99 | -2.65 |
| Diluted Shares Outstanding | 482.58K | 387.08K | 20.72M | 20.53M | 20.75M | 22.6M |
| Basic Shares Outstanding | 482.58K | 387.08K | 20.72M | 20.51M | 20.7M | 22.6M |
| Dividend Payout Ratio | - | - | - | - | - | - |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 28.91M | 64.34M | 151.1M | 122.88M | 112.09M | 129.81M |
| Cash & Short-Term Investments | 25.74M | 59.11M | 142.07M | 106.19M | 90.57M | 105.93M |
| Cash Only | 25.74M | 59.11M | 142.07M | 106.19M | 90.57M | 105.93M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 719K | 1.28M | 2.56M | 5.5M | 7.55M | 9.27M |
| Days Sales Outstanding | 41.94 | 77.25 | 71.68 | 89.41 | 70.14 | 65.95 |
| Inventory | 2.07M | 3.34M | 3.88M | 6.96M | 10.98M | 12.11M |
| Days Inventory Outstanding | 449.36 | 847.36 | 389.07 | 507.96 | 640.79 | 530.24 |
| Other Current Assets | 0 | 0 | 2.58M | 4.22M | 2.99M | 2.5M |
| Total Non-Current Assets | 200K | 436K | 1.45M | 2.06M | 3.14M | 3.6M |
| Property, Plant & Equipment | 174K | 410K | 1.43M | 2.03M | 3.11M | 3.57M |
| Fixed Asset Turnover | 35.96x | 14.76x | 9.15x | 11.06x | 12.63x | 14.35x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 26K | 26K | 26K | 27K | 27K | 27K |
| Total Assets | 29.11M | 64.78M | 152.55M | 124.94M | 115.23M | 133.41M |
| Asset Turnover | 0.21x | 0.09x | 0.09x | 0.18x | 0.34x | 0.38x |
| Asset Growth % | - | 1.23% | 1.35% | -0.18% | -0.08% | 0.16% |
| Total Current Liabilities | 8.61M | 7.98M | 5.91M | 8.09M | 7.86M | 10.76M |
| Accounts Payable | 437K | 483K | 510K | 1.72M | 1.88M | 2.58M |
| Days Payables Outstanding | 94.77 | 122.43 | 51.14 | 125.51 | 109.92 | 113.08 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.54M | 5.26M | 2.32M | 3.26M | 4.11M | 5.67M |
| Current Ratio | 3.36x | 8.07x | 25.57x | 15.19x | 14.25x | 12.06x |
| Quick Ratio | 3.12x | 7.65x | 24.92x | 14.33x | 12.86x | 10.94x |
| Cash Conversion Cycle | 396.53 | 802.18 | 409.6 | 471.86 | 601.01 | 483.11 |
| Total Non-Current Liabilities | 299.54M | 350.04M | 681K | 7.67M | 31.42M | 51.6M |
| Long-Term Debt | 18.99M | 19.28M | 0 | 6.75M | 29.22M | 49.27M |
| Capital Lease Obligations | 0 | 0 | 0 | 117K | 1.16M | 877K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 280.54M | 330.76M | 681K | 805K | 1.04M | 1.45M |
| Total Liabilities | 308.15M | 358.01M | 6.59M | 15.76M | 39.28M | 62.36M |
| Total Debt | 18.99M | 19.28M | 0 | 7.09M | 30.61M | 50.43M |
| Net Debt | -6.75M | -39.83M | -142.07M | -99.11M | -59.96M | -55.5M |
| Debt / Equity | - | - | - | 0.06x | 0.40x | 0.71x |
| Debt / EBITDA | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - |
| Interest Coverage | -5.93x | -4.66x | -11.70x | -257.74x | -23.96x | -13.53x |
| Total Equity | -279.04M | -293.24M | 145.96M | 109.18M | 75.95M | 71.06M |
| Equity Growth % | - | -0.05% | 1.5% | -0.25% | -0.3% | -0.06% |
| Book Value per Share | -578.23 | -757.56 | 7.04 | 5.32 | 3.66 | 3.14 |
| Total Shareholders' Equity | -279.04M | -293.24M | 145.96M | 109.18M | 75.95M | 71.06M |
| Common Stock | 5K | 4K | 204K | 207K | 209K | 253K |
| Retained Earnings | -337.57M | -351.68M | -394.75M | -436.18M | -477.38M | -537.35M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -189K | -190K | -198K | -207K | -207K | -206K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | -12.79M | -16.1M | -27.73M | -42.68M | -39.02M | -39.14M |
| Operating CF Margin % | -2.04% | -2.66% | -2.13% | -1.9% | -0.99% | -0.76% |
| Operating CF Growth % | - | -0.26% | -0.72% | -0.54% | 0.09% | -0% |
| Net Income | -14.63M | -14.11M | -43.08M | -41.43M | -41.2M | -59.97M |
| Depreciation & Amortization | 56K | 75K | 168K | 412K | 522K | 619K |
| Stock-Based Compensation | 66K | 132K | 1.91M | 3.89M | 6.3M | 19.05M |
| Deferred Taxes | 0 | 0 | 14.62M | 0 | 0 | 0 |
| Other Non-Cash Items | 3.06M | 657K | 229K | 25K | 158K | 203K |
| Working Capital Changes | -1.33M | -2.85M | -1.58M | -5.57M | -4.8M | 949K |
| Change in Receivables | -183K | -562K | -1.28M | -2.94M | -2.05M | -1.72M |
| Change in Inventory | -216K | -1.27M | -537K | -3.08M | -4.03M | -1.12M |
| Change in Payables | -1.05M | 46K | 27K | 1.21M | 165K | 698K |
| Cash from Investing | -106K | -311K | -1.18M | -685K | -591K | -1.36M |
| Capital Expenditures | -106K | -311K | -1.18M | -685K | -591K | -1.36M |
| CapEx % of Revenue | 0.02% | 0.05% | 0.09% | 0.03% | 0.02% | 0.03% |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 29.55M | 49.78M | 111.88M | 7.49M | 23.98M | 55.87M |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | -478K | 0 | 23K | -7K | 1.48M | 3.35M |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | -12.89M | -16.41M | -28.91M | -43.36M | -39.61M | -40.51M |
| FCF Margin % | -2.06% | -2.71% | -2.22% | -1.93% | -1.01% | -0.79% |
| FCF Growth % | - | -0.27% | -0.76% | -0.5% | 0.09% | -0.02% |
| FCF per Share | -26.71 | -42.39 | -1.40 | -2.11 | -1.91 | -1.79 |
| FCF Conversion (FCF/Net Income) | 0.87x | 1.14x | 0.64x | 1.03x | 0.95x | 0.65x |
| Interest Paid | 1.22M | 2.03M | 1.71M | 59K | 1.4M | 0 |
| Taxes Paid | 15K | 10K | 2K | 5K | 4K | 0 |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -29.51% | -32.47% | -44.51% | -81.58% |
| Return on Invested Capital (ROIC) | - | - | -501.05% | -456.98% | -248.07% | -282.88% |
| Gross Margin | 73.1% | 76.21% | 72.08% | 77.75% | 84.08% | 83.75% |
| Net Margin | -233.87% | -233.09% | -330.45% | -184.38% | -104.85% | -116.91% |
| Debt / Equity | - | - | - | 0.06x | 0.40x | 0.71x |
| Interest Coverage | -5.93x | -4.66x | -11.70x | -257.74x | -23.96x | -13.53x |
| FCF Conversion | 0.87x | 1.14x | 0.64x | 1.03x | 0.95x | 0.65x |
| Revenue Growth | - | -3.26% | 115.36% | 72.36% | 74.89% | 30.53% |
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| UNITED STATES | - | - | - | 47.17M |
| UNITED STATES Growth | - | - | - | - |
| GERMANY | - | - | - | 3.46M |
| GERMANY Growth | - | - | - | - |
| Other Countries | - | - | - | 665K |
| Other Countries Growth | - | - | - | - |
| U.S. | 9.15M | 18.02M | 35.11M | - |
| U.S. Growth | - | 97.02% | 94.83% | - |
| Germany | 3.25M | 3.48M | 3.69M | - |
| Germany Growth | - | 6.98% | 6.13% | - |
| Other countries | 639K | 971K | 494K | - |
| Other countries Growth | - | 51.96% | -49.12% | - |
CVRx, Inc. (CVRX) reported $56.0M in revenue for fiscal year 2024. This represents a 795% increase from $6.3M in 2019.
CVRx, Inc. (CVRX) grew revenue by 30.5% over the past year. This is strong growth.
CVRx, Inc. (CVRX) reported a net loss of $52.0M for fiscal year 2024.
CVRx, Inc. (CVRX) has a return on equity (ROE) of -81.6%. Negative ROE indicates the company is unprofitable.
CVRx, Inc. (CVRX) had negative free cash flow of $29.0M in fiscal year 2024, likely due to heavy capital investments.